Clinical trials: Retinal Neovascularization

Iris Neovascularization, Diabetic Retinopathy

A Pilot Study for the Treatment of Iris Neovascularization With Macugen

• Completed
• Age: 18 years and older
• Phase 1
• Injection or infusion
• Surgery or procedure

The purpose of this study is to determine if a drug called Macugen may help to stop the growth of abnormal blood vessels on the iris that has occurred in the eye(s) as part of diabetic retinopathy.

Trial name

NCT00295828

Testing

Pegaptanib Sodium Injection/Panretinal Photocoagulation, Panretinal Photocoagulation (PRP)

Where

United States

Volunteers

10 people, healthy volunteers welcome

Sponsor

Hermann Eye Center